Invitrogen™ LanthaScreen™ TR-FRET Androgen Receptor Co-activator Assay Kit

Ref.: BL-RE-102366Manufacturer ref.: A15878
€1,864.00 excl. VAT

The TR-FRET LanthaScreen™ Dandrogen Receiver Co-Activator Measurement Kit offers a sensitive and robust method for high-speed screening of potential d gastrointestinal receptor (AR) ligands as a potential recruitment agonist.

Content and storage
1 tube AR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)
1 tube Peptide (store at -5 to -30°C)
2 bottles TR-FRET Buffer (store at -5 to -30°C)
1 tube Tb-Anti-GST Ab (store at -5 to -30°C)
1 tube of DTT (store at -5 to -30°C)
Product range
LanthaScreen™
For use with (application)
Co-factorial interaction test, nuclear receptor assay
Ligand
AR
Product type
TR-FRET Dandrogen Receiver Co-Activator Measurement Kit
Brand
Invitrogen

The TR-FRET LanthaScreen™ Dandrogen Receiver Co-Activator Measurement Kit offers a sensitive and robust method for high-speed screening of potential d gastrointestinal receptor (AR) ligands as a potential recruitment agonist.

The TR-FRET LanthaScreen™ Dandrogen Receiver Co-Activator Dose Kit provides a sensitive and robust method for high-speed screening of potential dandrogen receptor (AR) ligands as agonists in the recruitment of co-activators or antagonists for the recruitment of agonist-dependent co-activators. In the agonist and antagonistic modes, the homogeneous mixture and reading assay uses a rat AR ligand binding domain (AR-LBD) marked with hexahistidine and glutathione-S-transferase (GST) (also available separately), terbium-labelled anti-GST antibody (Tb) and fluorescein-labelled co-activator peptide.

When performing the LanthaScreen TR-FRET co-activating assay in agonist mode (to identify agonist compounds), the AR-LBD is added to the ligand assay compounds, followed by a mixture of the fluoroescein co-activating peptide and Tb-labelled anti-GST antibody. After incubation at room temperature, the TR-FRET emission ratio 520:495 nm is calculated and used to determine EC50 from a response curve of the compound assay. This EC50 ligand is a composite value representing the amount of ligands needed to bind to the receptor, perform a conformational change and recruit the co-activating peptide (see figure).

When performing the LanthaScreen TR-FRET antagonist receptor co-activating assay (to identify antagonistic compounds), the AR-LBD is added to the ligand assay compounds followed by a DHT agonist mixture, fluorescein co-activating peptide and Tb-labelled anti-GST antibodies. The DHT concentration used in this mode is the EC80 concentration as determined by the first agonist-mode assay. An example of data produced in antagonist mode is shown in the figure below.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)15302098
Specifications
Product rangeLanthaScreen™
For use with (application)Co-factorial interaction test, nuclear receptor assay
LigandAR
Product typeTR-FRET Dandrogen Receiver Co-Activator Measurement Kit
No. of Assays800 x 20 μL attacks
Storage and shipping
Content and storage1 tube AR Ligand Binding Domain Recombinant Protein (store at -68 to -85°C)
1 tube Peptide (store at -5 to -30°C)
2 bottles TR-FRET Buffer (store at -5 to -30°C)
1 tube Tb-Anti-GST Ab (store at -5 to -30°C)
1 tube of DTT (store at -5 to -30°C)

Origin and customs

Manufacturer ref.A15878
Country of originUnited States
HS customs code3002 15 00 00
A question or a specific configuration?
Contact us for a quote.